SecBot SecBot
8-K ·Filed Oct 30, 2026

PTHS

Pelthos Therapeutics Inc.
NEUTRAL
Impact 6/10
Processed53m ago SEC0001104659-26-120457
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-120457
Document: tm2628523d1_ex10-6.htm0001104659-26-120457
15 reports for PTHS
Performance horizon
75% Hit rate @ T+5 3 of 4 directional calls Went positive at some point 4 of 4 best @ T+20▲ +24.35%Aug 13, 2026
Filters
Rows
Reports for PTHS, sortable and filterable
TypeNow
Oct 30, 2026
today
425
NEUTRAL ★ 6/10
$15.68awaiting T+5awaiting T+5$11.01 (−29.78%)
Oct 30, 2026
today
8-K
NEUTRAL ★ 6/10
$20.00awaiting T+5awaiting T+5$11.01 (−44.95%)
Oct 30, 2026
today
Press Release
NEUTRAL ★ 5/10
$15.68awaiting T+5awaiting T+5$11.01 (−29.78%)
Oct 1, 2026
28d ago
8-K
NEUTRAL ★ 2/10
$20.60 $20.50▼ −0.49%▼ −1.65%$11.01 (−46.55%)
Aug 13, 2026
11w ago
8-K
BEARISH ★ 6/10
$28.95 $26.66▲ +7.91%▲ +5.95%$11.01 (+61.97%)
Aug 3, 2026
12w ago
Press Release
NEUTRAL ★ 1/10
$26.84awaiting T+5awaiting T+5$11.01 (−58.98%)
Jun 17, 2026
19w ago
Insider Cluster
BULLISH ★ 6/10
$29.00 $29.21▲ +0.72%▲ +2.39%$11.01 (−62.03%)
May 28, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$26.47 $25.55▼ −3.48%▼ −0.95%$11.01 (−58.41%)
May 22, 2026
22w ago
144
NEUTRAL ★ 2/10
$26.66 $26.20▼ −1.73%▼ −3.40%$11.01 (−58.70%)
May 21, 2026
23w ago
8-K
BEARISH ★ 6/10
$26.66 $26.20▲ +1.73%▲ +3.38%$11.01 (+58.70%)
Showing 10 of 15

US Market Status

Market Open · Closes in 5h 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026

Fresh PTHS Intelligence

Analysis is for subscribers only.

Subscribe for Full Access